is semaglutide fda approved for mash GLP-1 BREAKTHROUGH: APPROVES TREATMENT SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, now the first GLP-1 therapy to treat (Metabolic Dysfunction–Associated FDA Approves Semaglutide for MASH

Researchers at the University of Chicago Medicine found last summer that, despite other health benefits such as reduced risk of strokes and heart attacks, GLP-1 injections fell well short of standard benchmarks for cost-effectiveness for governments because of their high cost

Jennifer Ashton, a board-certified OB-GYN and board-certified in obesity medicine, echoed Aronne, saying it's important to understand that obesity is a chronic condition

Unlike mitochondrial fission, pharmacological activation of mitophagy is associated with angiotensin II and atrial natriuretic peptide levels, reducing cardiomyocyte apoptosis and myocardial fibrosis in a model of pressure overload-induced chronic cardiac insufficiency [75]

Additionally, compounded GLP-1 alternatives like daily liraglutide or weekly tirzepatide can provide more accessible pathways when cost or insurance coverage presents a barrier